What a Normal TSH Doesn't Mean

Thyroid dysfunction is among the most common endocrine conditions in the UK, affecting an estimated 1 in 20 people. It is also among the most commonly undertested and undertreated — not because medicine is ignoring it, but because the standard assessment tool, TSH alone, misses a significant proportion of functional thyroid insufficiency.

This is not a fringe position. The debate within endocrinology about the adequacy of TSH-only testing has been ongoing for decades. The clinical reality experienced by thousands of patients — significant hypothyroid symptoms with a “normal” TSH — is not imaginary. It is a logical consequence of using a pituitary output marker as a proxy for thyroid hormone adequacy at the tissue level, and of using a reference range so wide that it encompasses people who feel profoundly unwell.

TSH Is Not a Thyroid Test — It Is a Pituitary Test

This is the single most important conceptual clarification in thyroid health. TSH — thyroid stimulating hormone — is produced by the pituitary gland in response to how much thyroid hormone the pituitary perceives in circulation. It is a feedback signal, not a direct measurement of thyroid hormone activity at the tissue level.

A normal TSH tells you the pituitary is seeing adequate thyroid hormone in the blood. It does not tell you: whether that hormone is being converted from inactive T4 to active T3 in peripheral tissues; whether reverse T3 is blocking T3 receptor sites; whether autoimmune antibodies are gradually destroying thyroid tissue; or whether tissue thyroid hormone levels are adequate for the individual patient’s metabolic demands.

The T4 to T3 Conversion Problem

The thyroid gland produces predominantly T4 (approximately 80%) and a small amount of T3 (approximately 20%). T4 is relatively inactive — it must be converted to T3 by deiodinase enzymes in the liver, kidney, gut, and other peripheral tissues. T3 is the metabolically active form that binds thyroid hormone receptors and drives cellular metabolism.

T4 to T3 conversion requires selenium as the cofactor for type 1 and type 2 deiodinase enzymes. It is impaired by chronic stress and elevated cortisol (which shunts T4 toward reverse T3 instead of active T3), by severe caloric restriction, by gut dysbiosis (approximately 20% of T4 to T3 conversion occurs in the gut via intestinal bacteria), by iron deficiency, and by chronic inflammation.

A patient with a normal TSH, normal T4, but low free T3 and elevated reverse T3 has a conversion problem, not a production problem. Levothyroxine (T4) will not help them — it is already converting poorly to T3. They need the conversion problem addressed: selenium adequacy, stress management, gut health optimisation, and potentially T3 supplementation. None of this is visible on TSH alone.

Hashimoto’s — The Autoimmune Component That Precedes TSH Abnormality

Hashimoto’s thyroiditis is the most common cause of hypothyroidism in iodine-sufficient populations. It is an autoimmune condition in which TPO antibodies (and sometimes TgAb antibodies) gradually destroy thyroid tissue over years to decades before TSH rises above normal range. During that extended prodromal period, a patient can have significant autoimmune thyroid disease with normal TSH and a range of symptoms including fatigue, cognitive fog, weight gain, and mood disruption.

TPO antibodies are almost never measured in standard NHS care unless TSH is already abnormal. Functional assessment includes TPO and TgAb antibodies as routine components of thyroid evaluation — because identifying autoimmune thyroid disease early, and implementing dietary and lifestyle interventions (selenium, gluten removal, vitamin D optimisation, stress management) that reduce antibody titre, is clinically meaningful in the preclinical phase.

TSH alone is a blunt instrument applied to a precision system. It is asking a general about what is happening at the front line. Sometimes the general’s report is accurate. Sometimes the front line is struggling in ways the general hasn’t yet registered. Free T3, reverse T3, and antibody testing are the front-line reports.